GlassScriptPhysician profile
Christopher G Katcherian
NPI 1316106685
$1,556.93
in general payments reported to CMS, 2019-2025
11 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.42 · 2021: $117 · 2022: $143 · 2023: $195 · 2024: $512 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $721.65 | 2023-2025 | Variax, Pangea, Evolve |
| Axogen | $175.74 | 2021-2025 | |
| Depuy Synthes Sales INC. | $173.11 | 2025 | Motoband |
| Endo USA, INC. | $159.20 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $138.67 | 2022-2023 | Xiaflex |
| Smith+Nephew, INC. | $84.97 | 2021 | |
| Bone Support INC. | $33.42 | 2020 | |
| Acumed LLC | $20.64 | 2022 | |
| Radius Health, INC. | $17.64 | 2023 | Tymlos |
| Convatec INC. | $17.15 | 2024 | |
| Sonex Health, INC. | $14.74 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Katcherian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.